Literature DB >> 18538730

The ups and downs of SRC regulation: tumor suppression by Cbp.

Marilyn D Resh1.   

Abstract

Tight control of the tyrosine kinase activity of c-Src is critical for regulating its oncogenic potential. In a recent issue of Molecular Cell, Oneyama et al. (2008a) report that the membrane-bound adaptor protein Cbp (also known as PAG) can suppress c-Src-mediated cell transformation and tumorigenesis by binding and sequestering c-Src within lipid rafts. Cbp is also a raft-associated binding partner for Csk, a negative regulator of c-Src. However, the authors show that Cbp-mediated Src suppression is Csk independent. These findings suggest that Cbp is a tumor suppressor whose expression is downregulated during Src-driven cancer progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18538730     DOI: 10.1016/j.ccr.2008.05.011

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  7 in total

1.  Src tyrosine kinase regulates adhesion and chemotaxis in Waldenstrom macroglobulinemia.

Authors:  Hai T Ngo; Abdel Kareem Azab; Mena Farag; Xiaoying Jia; Molly M Melhem; Judith Runnels; Aldo M Roccaro; Feda Azab; Antonio Sacco; Xavier Leleu; Kenneth C Anderson; Irene M Ghobrial
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

2.  Prostaglandin E2 promotes lung cancer cell migration via EP4-betaArrestin1-c-Src signalsome.

Authors:  Jae Il Kim; Vijayabaskar Lakshmikanthan; Nicole Frilot; Yehia Daaka
Journal:  Mol Cancer Res       Date:  2010-03-30       Impact factor: 5.852

3.  Transforming potential of Src family kinases is limited by the cholesterol-enriched membrane microdomain.

Authors:  Chitose Oneyama; Takuya Iino; Kazunobu Saito; Kei Suzuki; Akira Ogawa; Masato Okada
Journal:  Mol Cell Biol       Date:  2009-10-12       Impact factor: 4.272

4.  Phosphatase of regenerating liver 3 (PRL3) provokes a tyrosine phosphoproteome to drive prometastatic signal transduction.

Authors:  Chad D Walls; Anton Iliuk; Yunpeng Bai; Mu Wang; W Andy Tao; Zhong-Yin Zhang
Journal:  Mol Cell Proteomics       Date:  2013-09-12       Impact factor: 5.911

5.  Elevated MED28 expression predicts poor outcome in women with breast cancer.

Authors:  Nam K Yoon; Erin L Maresh; Yahya Elshimali; Ai Li; Steve Horvath; David B Seligson; David Chia; Lee Goodglick
Journal:  BMC Cancer       Date:  2010-06-28       Impact factor: 4.430

6.  Src-mediated caveolin-1 phosphorylation affects the targeting of active Src to specific membrane sites.

Authors:  Efrat Gottlieb-Abraham; Dmitry E Shvartsman; John C Donaldson; Marcelo Ehrlich; Orit Gutman; G Steven Martin; Yoav I Henis
Journal:  Mol Biol Cell       Date:  2013-10-16       Impact factor: 4.138

7.  Docosahexaenoic Acid Inhibits Tumor Promoter-Induced Urokinase-Type Plasminogen Activator Receptor by Suppressing PKCδ- and MAPKs-Mediated Pathways in ECV304 Human Endothelial Cells.

Authors:  Sen Lian; Yong Xia; Thi Thinh Nguyen; Trong Thuan Ung; Hyun Joong Yoon; Nam Ho Kim; Kyung Keun Kim; Young Do Jung
Journal:  PLoS One       Date:  2016-09-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.